No new shares issued during the second quarter — common shares outstanding of 20,234,993 at June 30, 2026, unchanged from March 31, 2026; shares outstanding increased from 5,160,383 at December 31, ...
US Treasury targets Iran's financial networks amid nuclear talks. Final nuclear deal by August 13, 2026 at 0.5% YES.
Facility enhances financial flexibility and supports continued execution of the Company's disciplined growth strategy ...
Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that the Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results